Literature DB >> 8929735

Neurological sequelae of the dancing eye syndrome.

K R Pohl1, J Pritchard, J Wilson.   

Abstract

UNLABELLED: Fifty-four patients with dancing eye syndrome (DES), presenting over a 25-year period, were reviewed retrospectively. One third of them were on active follow up at the time of the study. Malignancy was uncommon, diagnosed in only 4 patients, neuroblastoma in 3 cases and acute lymphoblastic leukaemia (ALL) in 1. An intercurrent illness preceded onset of DES in 51% of the children and was of equivocal significance. There was no clear temporal relationship to immunization. The acute phase of the illness was severe and caused total immobilization in 88% of patients. A favourable initial response to treatment with prednisolone or corticotrophin gel was observed in all patients. Although corticotrophin seemed to produce a more rapid response, overall improvement was similar with both treatments. Long-term neurological morbidity was a major problem with 91% of children suffering either persisting symptoms or repeated relapses. A persisting disability was found in 88% and was considered severe in 61% of patients. No features prognostic of neurological severity or outcome were identified.
CONCLUSION: Demonstrable malignancy is uncommon in the dancing eye syndrome. The neurological legacy of DES is often evident well into adult life.

Entities:  

Mesh:

Year:  1996        PMID: 8929735     DOI: 10.1007/bf01953945

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  43 in total

1.  A hypothetical explanation of saccadic oscillations.

Authors:  D S Zee; D A Robinson
Journal:  Ann Neurol       Date:  1979-05       Impact factor: 10.422

2.  The Transformation of a Malignant Paravertebral Sympathicoblastoma into a Benign Ganglioneuroma.

Authors:  H Cushing; S B Wolbach
Journal:  Am J Pathol       Date:  1927-05       Impact factor: 4.307

3.  Neuronal proteins and paraneoplastic syndromes.

Authors:  S E Kornguth
Journal:  N Engl J Med       Date:  1989-12-07       Impact factor: 91.245

4.  Unusual manifestations of neuroblastoma: chronic diarrhea, polymyoclonia-opsoclonus, and erythrocyte abnormalities.

Authors:  T H Williams; R F House; E O Burgert; H B Lynn
Journal:  Cancer       Date:  1972-02       Impact factor: 6.860

5.  Opsoclonus, body tremulousness, and benign encephalitis.

Authors:  D G Cogan
Journal:  Arch Ophthalmol       Date:  1968-05

6.  Opsoclonus-myoclonus syndrome in acute cerebellar ataxia--clinical and electrophysiological observations of an adult case--.

Authors:  K Tamura; Y Kuroiwa
Journal:  Folia Psychiatr Neurol Jpn       Date:  1971

7.  Opsomyoclonus and neuroblastoma. Response to ACTH.

Authors:  B G Nickerson; J J Hutter
Journal:  Clin Pediatr (Phila)       Date:  1979-07       Impact factor: 1.168

8.  Eye movements in children with opsoclonus-polymyoclonus.

Authors:  F S Shawkat; C M Harris; J Wilson; D S Taylor
Journal:  Neuropediatrics       Date:  1993-08       Impact factor: 1.947

9.  [Neuroblastoma: paraneoplastic diseases and late complications (author's transl)].

Authors:  A M Holschneider; H Geiger; N Bolkenius; G Janka; F Lampert
Journal:  Monatsschr Kinderheilkd       Date:  1977-02

10.  Long-term outcome in children with opsoclonus-myoclonus and ataxia and coincident neuroblastoma.

Authors:  P S Koh; J G Raffensperger; S Berry; M B Larsen; H S Johnstone; P Chou; S R Luck; M Hammer; S L Cohn
Journal:  J Pediatr       Date:  1994-11       Impact factor: 4.406

View more
  7 in total

Review 1.  Autoimmune encephalitis in children.

Authors:  Thaís Armangue; Mar Petit-Pedrol; Josep Dalmau
Journal:  J Child Neurol       Date:  2012-08-29       Impact factor: 1.987

2.  Paraneoplastic Opsoclonus-Myoclonus Syndrome: initial presentation of non-Hodgkins lymphoma.

Authors:  Ashwani Kumar; Walter A Lajara-Nanson; Robert W Neilson
Journal:  J Neurooncol       Date:  2005-05       Impact factor: 4.130

3.  Neuroblastic tumors associated with opsoclonus-myoclonus syndrome: histological, immunohistochemical and molecular features of 15 Italian cases.

Authors:  Claudio Gambini; Massimo Conte; Gabriella Bernini; Paola Angelini; Andrea Pession; Paolo Paolucci; Alberto Donfrancesco; Edvige Veneselli; Katia Mazzocco; Gian Paolo Tonini; Lizzia Raffaghello; Carlo Dominici; Adriana Morando; Francesca Negri; Anna Favre; Bruno De Bernardi; Vito Pistoia
Journal:  Virchows Arch       Date:  2003-04-23       Impact factor: 4.064

4.  Paraneoplastic neurologic disorders in children.

Authors:  Elizabeth M Wells; Josep Dalmau
Journal:  Curr Neurol Neurosci Rep       Date:  2011-04       Impact factor: 5.081

5.  Long-term outcome of ten children with opsoclonus-myoclonus syndrome.

Authors:  Andrea Klein; Bernhard Schmitt; Eugen Boltshauser
Journal:  Eur J Pediatr       Date:  2006-11-07       Impact factor: 3.183

Review 6.  Paraneoplastic neurologic syndromes in children: a review article.

Authors:  Samin Alavi
Journal:  Iran J Child Neurol       Date:  2013

7.  Opsoclonus-myoclonus syndrome with severe clinical course and beneficial outcome: A case report.

Authors:  Ewa Koziorowska-Gawron; Magdalena Koszewicz; Joanna Bladowska; Maria Ejma; Slawomir Budrewicz
Journal:  Medicine (Baltimore)       Date:  2021-04-09       Impact factor: 1.817

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.